![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1537032-82-8
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Avelumab REF: TM-T9903CAS: 1537032-82-8 | 95.00% - 98.3% (SEC-HPLC) | 274,00 €~938,00 € | Mar 11 Mar 25 |
![]() | Avelumab - in PBS buffer REF: 3D-BA165583CAS: 1537032-82-8 | Min. 95% | 1.049,00 € | Mar 25 Mar 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Avelumab
CAS:1537032-82-8
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody. Avelumab shows potential antibody-dependent cell-mediated cytotoxicity.
Pureza:
95.00% - 98.3% (SEC-HPLC)
Forma y color:
Liquid
Peso molecular:
143.8 kDa
Ref: TM-T9903
1mg | 274,00 € | ||
5mg | 662,00 € | ||
10mg | 938,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Avelumab - in PBS buffer
CAS:1537032-82-8
Monoclonal antibody against PDL-1; targeted immunotherapy for cancer
Pureza:
Min. 95%
Ref: 3D-BA165583
1mg | 1.049,00 € |
Entrega estimada en Estados Unidos, el Martes 25 de Marzo de 2025